1. ivreb777
2. GoldTrader
3. jshjohwalla
4. ray66695
5. t66860
1.GoldTrader 03/19/2018
Viveve Announces FDA Approval of IDE to Conduct VIVEVE II Clinical Study
2.GoldTrader 01/31/2018
Viveve Announces Expansion of CMRF Technology Platform into Stress Urinary Incontinence Market
3.jshjohwalla 02/08/2018
Announces pricing of 10 mln shares of common stock at $3.00/share
4.ivreb777 02/27/2018
Viveve to Present at March Investor Conferences
5.ivreb777 03/15/2018
Misses EPS loss estimates by $0.07
6.ivreb777 02/07/2018
Commenced an underwritten public offering of shares of its common stock
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW